[Türkçe]
Turkish Society of Cardiology Cardiooncology Bulletin Year: 2 Number: 4 / 2024


Turkish Society of Cardiology
Cardiooncology

President:
Dr. Elif Eroğlu Büyüköner
Coordinator for the
Board of Directors
Dr. Yusuf Ziya Şener

Members
Dr. Kartal Emre Aslanger
Dr. Fatma Nihan Turhan Çağlar
Dr. Uğur Nadir Karakulak
Dr. Ertuğrul Okuyan
Dr. Evin Bozçalı Polat
Dr. Nafia İnan Kardelen Ohtaroğlu Tokdil
Dr. Omaç Tüfekçioğlu
Dr. Demet Menekşe Gerede Uludağ
 


Turkish Society of Cardiology Young Cardiologists Bulletin / "" Nisan 2024 (4)
Issue Summary
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)- Amyloid light-chain cardiac amyloidosis
Dr. Ezgi Çamlı Babayiğit

Cardiac Troponin in Patients with Light Chain and Transthyretin Cardiac Amyloidosis
Dr. Ezgi Çamlı Babayiğit

Prognostic Mortality Factors in Advanced Light Chain Cardiac Amyloidosis: A Prospective Cohort Study
Dr. Ezgi Çamlı Babayiğit

Prognostic Implications of Prematüre Ventricular Contractions and Non-sustained Ventricular Tachycardia in Light-chain Cardiac Amyloidosis
Dr. İrem Çamlıbel Al

Atrial Electrofunctional Predictors of Incident Atrial Fibrillation in Cardiac Amyloidosis
Dr. İrem Çamlıbel Al

Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
Dr. İrem Çamlıbel Al

A New Staging System Using Right Atrial Strain in Patients with İmmunoglobulin Light-Chain Cardiac Amyloidosis
Dr. Ahmet Caner Canpolat

Cardiac Amyloidosis is not A Single Disease: A Multiparametric Comparison Between the Light Chain and Transthyretin Forms
Dr. Ahmet Caner Canpolat

Prognostic Value of Native T1 and Extracellular Volume in patients with Immunoglubin Light-Chain Amyloidosis
Dr. Ahmet Caner Canpolat
 2024 © Turkish Society of Cardiology.